未登录US Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab
Lemery, Steven J.; Zhang, Jenny; Rothmann, Mark D.; Yang, Jun; Earp, Justin; Zhao, Hong; McDougal, Andrew; Pilaro, Anne; Chiang, Raymond; Gootenberg, Joseph E.; Keegan, Patricia; Pazdur, Richard
分享
收藏
分享
收藏
分享
收藏
分享
收藏